Alprazolam
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription benzodiazepine (Schedule IV controlled substance) approved for generalized anxiety disorder and panic disorder. One of the most commonly prescribed benzodiazepines with rapid onset of action. Due to its relatively short half-life and high potency, alprazolam carries a higher risk of rebound anxiety and dependence compared to longer-acting benzodiazepines. Intended for short-term use. Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription benzodiazepine (Schedule IV controlled substance) approved for generalized anxiety disorder and panic disorder. NutriStack rates the supporting evidence as strong. Common adult dosing is 0.25–4 mg daily in divided doses (as prescribed by your physician), though a prescriber sets the actual dose. This profile indexes 11 sources.
The bottom line
Evidence rating strong. Most-documented uses: rapid anxiety relief, panic attack reduction, acute anxiolytic effect. 11 sources indexed (1995–2024), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Binds to the benzodiazepine site on GABA-A receptors, enhancing the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). This increases chloride ion conductance, hyperpolarizes neuronal membranes, and reduces neuronal excitability, producing anxiolytic, sedative, muscle relaxant, and anticonvulsant effects.2,8
Dosing & protocol.
Rapidly absorbed. Can be taken with or without food. Do not crush, chew, or break extended-release tablets.
Full safety detail.
Side effects
- Sedation and drowsiness
- Cognitive impairment
- Dizziness
- Dependence and withdrawal
- Rebound anxiety
- Ataxia
- Memory impairment
- Paradoxical agitation (rare)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Pharmacological treatments in panic disorder in adults: a network meta-analysis.PMIDGuaiana G, Meader N, Barbui C et al. · Cochrane Database of Systematic Reviews · 2023
Cochrane network meta-analysis found alprazolam among the most effective pharmacological treatments for panic disorder, with significantly better response than placebo; SSRIs and SNRIs also effective but alprazolam showed faster onset of action.
- 2Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.PMIDSlee A, Nazareth I, Bondaronek P et al. · Lancet · 2019
Network meta-analysis of 89 studies found benzodiazepines including alprazolam effective for GAD but noted concerns about dependence, withdrawal, and inferior long-term outcomes compared to antidepressants.
- 3Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effectPMIDSrisurapanont M, Boonyanaruthee V · Journal of the Medical Association of Thailand = Chotmaihet thangphaet · 1997
Srisurapanont M, Boonyanaruthee V. Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 1997
- 4Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depressionPMIDJonas JM, Hearron AE Jr · Journal of clinical psychopharmacology · 1996
Jonas JM, Hearron AE Jr. Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. Journal of clinical psychopharmacology. 1996
- 5Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysisPMIDBoyer W · International clinical psychopharmacology · 1995
Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. International clinical psychopharmacology. 1995
Reviews & position papers
1- 6Signal mining and risk analysis of Alprazolam adverse events based on the FAERS databasePMIDHuang F, San X, Liu Q et al. · Scientific reports · 2024
Huang F, San X, Liu Q et al.. Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database. Scientific reports. 2024
Observational studies
1- 7Safety of Alprazolam Use in Pregnancy in Western Australia: A Retrospective Cohort Study Using Linked Health DataPMIDKelty E, Chitty K, Preen DB · Journal of psychoactive drugs · 2024
Kelty E, Chitty K, Preen DB. Safety of Alprazolam Use in Pregnancy in Western Australia: A Retrospective Cohort Study Using Linked Health Data. Journal of psychoactive drugs. 2024
Reference material
4- 8Offidani E et al. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom. 2013.Source linkedPMID
- 9Ait-Daoud N et al. A review of alprazolam use, misuse, and withdrawal. J Addict Med. 2018.Source linkedPMID
- 10Li J et al. Effects of tranquilization therapy in elderly patients suffering from chronic non-communicable diseases: A meta-analysis. Acta Pharm. 2023.Source linkedPMID
- 11George TT, Tripp J. Alprazolam. 2026Source linkedPMID
Common questions.
Quick answers about Alprazolam, drawn from the data on this page.
What is Alprazolam?
Prescription benzodiazepine (Schedule IV controlled substance) approved for generalized anxiety disorder and panic disorder. One of the most commonly prescribed benzodiazepines with rapid onset of action. Due to its relatively short half-life and high potency, alprazolam carries a higher risk of rebound anxiety and dependence compared to longer-acting benzodiazepines. Intended for short-term use. Dosage must be determined by your prescribing physician.
What is Alprazolam used for?
Commonly cited benefits of Alprazolam include: Rapid anxiety relief; Panic attack reduction; Acute anxiolytic effect; Sedation for acute distress. NutriStack rates the overall evidence as strong.
What is a typical dose of Alprazolam?
A typical adult dose of Alprazolam is 0.25–4 mg daily in divided doses (as prescribed by your physician). The commonly recommended form is Tablet, extended-release tablet, or orally disintegrating tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Alprazolam?
Reported side effects include sedation and drowsiness, cognitive impairment, dizziness, dependence and withdrawal, rebound anxiety, ataxia. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Alprazolam?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Alprazolam in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.